Drug-coated balloons for small coronary artery disease (BASKET-SMALL 2): an open-label randomised non-inferiority trial - The Lancet
Drug Coated Balloons safer than Drug Eluting Stents for small vessel coronary artery disease, confirms a BASKET-SMALL 2 trial
Drug-coated balloons for small coronary artery disease (BASKET-SMALL 2): an open-label randomised non-inferiority trial - The Lancet
Long-term efficacy and safety of drug-coated balloons versus drug-eluting stents for small coronary artery disease (BASKET-SMALL 2): 3-year follow-up of a randomised, non-inferiority trial - The Lancet
Objectives and Designs of the Clinical Trials presented at ESC 2018
Drug-coated balloons for small coronary artery disease in patients with chronic kidney disease: a pre-specified analysis of the BASKET-SMALL 2 trial | Clinical Research in Cardiology
Drug-coated balloons for small coronary artery disease (BASKET-SMALL 2): an open-label randomised non-inferiority trial - The Lancet
Drug-Coated Balloon for De Novo Coronary Artery Disease: JACC State-of-the-Art Review - ScienceDirect
Trial Scorecard: BASKET-SMALL 2
Drug-coated balloons for small coronary artery disease (BASKET-SMALL 2): an open-label randomised non-inferiority trial - The Lancet
Long-term efficacy and safety of drug-coated balloons versus drug-eluting stents for small coronary artery disease (BASKET-SMALL 2): 3-year follow-up of a randomised, non-inferiority trial - The Lancet
Drug-Coated Balloons for Small Coronary Artery Disease: BASKET-SMALL 2 - ppt download
Drug-coated balloons for small coronary artery disease (BASKET-SMALL 2): an open-label randomised non-inferiority trial - The Lancet
Long-term efficacy and safety of drug-coated balloons versus drug-eluting stents for small coronary artery disease (BASKET-SMALL 2): 3-year follow-up of a randomised, non-inferiority trial - The Lancet
An overview of precision oncology basket and umbrella trials for clinicians - Park - 2020 - CA: A Cancer Journal for Clinicians - Wiley Online Library
Drug-Coated Balloons for Coronary Artery Disease: Third Report of the International DCB Consensus Group | JACC: Cardiovascular Interventions
JCDD | Free Full-Text | Impact of Insulin-Treated Compared to Non-Insulin-Treated Diabetes Mellitus on Outcome of Percutaneous Coronary Intervention with Drug-Coated Balloons versus Drug-Eluting Stents in De Novo Coronary Artery Disease: The
Drug‐Coated balloons vs drug‐eluting stents for the treatment of small coronary artery disease: A meta‐analysis of randomized trials - Sanz Sánchez - 2021 - Catheterization and Cardiovascular Interventions - Wiley Online Library
Drug-Coated Balloon for Small Coronary Artery Disease in Patients With and Without High-Bleeding Risk in the BASKET-SMALL 2 Tria
Drug-coated balloons for small coronary artery disease (BASKET-SMALL 2): an open-label randomised non-inferiority trial - The Lancet
The Lancet on Twitter: "NEW Research—Long-term efficacy and safety of drug-coated balloons vs drug-eluting stents for small coronary artery disease (BASKET-SMALL 2): 3-year follow-up of a randomised, non-inferiority trial https://t.co/Fmi4sZTSdU https ...
DCB Only Followed by Provisional Stenting: Insights from BASKET-SMALL 2 Trial | tctmd.com
Sex-specific inequalities in the use of drug-coated balloons for small coronary artery disease: a report from the BASKET-SMALL 2 trial | springermedizin.de
Drug‐coated balloons for de novo lesions in small coronary arteries: rationale and design of BASKET‐SMALL 2 - Gilgen - 2018 - Clinical Cardiology - Wiley Online Library
BASKET-SMALL 2
